Jeff Lyon. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antibodies, Monoclonal, Humanized/therapeutic useDisease ProgressionDrug DiscoveryFemaleHumansImmunologic Factors/therapeutic useMaleMultiple Sclerosis/drug therapyMultiple Sclerosis/physiopathology
Substances: See more » Antibodies, Monoclonal, HumanizedImmunologic Factorsocrelizumab
Year: 2018 PMID: 29238808 DOI: 10.1001/jama.2017.14033
Source DB: PubMed Journal: JAMA ISSN: 0098-7484 Impact factor: 56.272